Waters Corporation $WAT Shares Sold by Robeco Schweiz AG

Robeco Schweiz AG trimmed its position in shares of Waters Corporation (NYSE:WAT) by 15.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 128,250 shares of the medical instruments supplier’s stock after selling 23,945 shares during the quarter. Robeco Schweiz AG’s holdings in Waters were worth $56,352,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in WAT. Anchor Investment Management LLC acquired a new stake in Waters during the 1st quarter valued at $27,000. Resources Management Corp CT ADV acquired a new stake in shares of Waters in the first quarter worth $27,000. PenderFund Capital Management Ltd. acquired a new stake in shares of Waters in the second quarter worth $28,000. Vision Retirement LLC acquired a new stake in shares of Waters in the first quarter worth $29,000. Finally, Bollard Group LLC purchased a new position in shares of Waters during the first quarter valued at $29,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Stock Down 0.5%

WAT stock opened at $453.42 on Friday. Waters Corporation has a 12-month low of $282.77 and a 12-month high of $465.36. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The company has a market cap of $44.55 billion, a price-to-earnings ratio of 113.07, a PEG ratio of 2.64 and a beta of 1.15. The company has a 50 day moving average of $424.37 and a two-hundred day moving average of $381.40.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.01 by $0.04. Waters had a net margin of 3.58% and a return on equity of 11.27%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. During the same quarter last year, the business posted $2.95 EPS. The company’s revenue for the quarter was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities analysts anticipate that Waters Corporation will post 14.56 earnings per share for the current fiscal year.

Insider Buying and Selling at Waters

In related news, Director Christopher Kuebler sold 3,626 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares in the company, valued at approximately $7,086,515.52. This trade represents a 16.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on WAT shares. TD Cowen upped their price target on Waters from $475.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, October 13th. Guggenheim increased their price objective on Waters from $440.00 to $490.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. The Goldman Sachs Group raised their price objective on Waters from $465.00 to $515.00 and gave the stock a “buy” rating in a research report on Monday, September 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $400.00 target price on shares of Waters in a research note on Wednesday, August 5th. Finally, Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $443.79.

Waters Profile

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.